Grantham, Mayo, Van Otterloo & Co (GMO)
ESRX

Grantham, Mayo, Van Otterloo & Co (GMO)’s Express Scripts Holding Company ESRX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-308,600
Closed -$29.3M – 615
2018
Q3 		$29.3M Sell
308,600
-1,012,308
-77% -$86.3M 0.2% 81
2018
Q2 		$102M Buy
1,320,908
+1,112,608
+534% +$83.5M 0.72% 41
2018
Q1 		$14.4M Buy
+208,300
New +$15.9M 0.09% 128
2017
Q3 		– Sell
-3,200
Closed -$204K – 662
2017
Q2 		$204K Sell
3,200
-500
-14% -$31.4K ﹤0.01% 551
2017
Q1 		$244K Buy
+3,700
New +$255K ﹤0.01% 474
2016
Q3 		– Sell
-1,127,881
Closed -$85.5M – 615
2016
Q2 		$85.5M Sell
1,127,881
-496,676
-31% -$36.5M 0.35% 68
2016
Q1 		$112M Sell
1,624,557
-1,578,735
-49% -$113M 0.42% 57
2015
Q4 		$280M Sell
3,203,292
-1,388,363
-30% -$119M 1.01% 24
2015
Q3 		$372M Sell
4,591,655
-6,062,839
-57% -$528M 1.29% 20
2015
Q2 		$948M Sell
10,654,494
-10,407,822
-49% -$909M 3.06% 11
2015
Q1 		$1.83B Sell
21,062,316
-3,184,014
-13% -$267M 5.45% 1
2014
Q4 		$2.05B Sell
24,246,330
-1,288,794
-5% -$101M 5.53% 1
2014
Q3 		$1.8B Buy
25,535,124
+7,290,342
+40% +$519M 4.78% 2
2014
Q2 		$1.26B Buy
18,244,782
+5,685,105
+45% +$400M 3.43% 8
2014
Q1 		$943M Sell
12,559,677
-1,244,866
-9% -$93.2M 2.46% 12
2013
Q4 		$970M Sell
13,804,543
-286,597
-2% -$18.7M 2.35% 13
2013
Q3 		$871M Sell
14,091,140
-1,828,767
-11% -$118M 2.29% 14
2013
Q2 		$982M Buy
+15,919,907
New +$959M 2.56% 14

Other funds holding ESRX

SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
BSPF
British Steel Pension Fund London, United Kingdom $410M AUM 11.96% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
AWM
Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.41B AUM 14.87% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ESRX Position: Q4 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 308,600 shares — an estimated $29.3M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ESRX in Q2 2013 and held it in 18 quarters. The position peaked at $2.05B in Q4 2014. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 308,600 Express Scripts Holding Company shares in Q4 2018, an estimated $29.3M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 18 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Express Scripts Holding Company position peaked at $2.05B in Q4 2014.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2018, filed 13 Feb 2019.